InvestorsHub Logo

blackbandit

10/12/16 3:39 PM

#748 RE: bkeezy #747

I disagree. I agree IVF is well entrenched because it has been the only option. But with the Invocell matching the quality of IVF at half the price, why do you not think that insurance companies will eventually require that the less expensive option is used just like they do with generic drugs over name brands when available? It will get down to the clinic that offers it. So far it is looking like IVF clinics are agreeing to also offer Invocell. If you are the Dr, and after you are trained and have developed confidence with invocell, at some point you will have a preference on which to offer based on how easy to use, results, price, etc. Right now your doc can't offer it yet, but a year from now he might be pushing everyone towards it. Tell me why the Invocell can not overtake IVF eventually, 5 yrs, 10 yrs or so down the road?

blackbandit

10/12/16 3:48 PM

#749 RE: bkeezy #747

also you refer to premium choice being IVF. What makes you think that. What I have read lists invocell advantages over IVF in addition to being half the cost. I haven't read any IVF advantages over Invocell. Also the FDA does not approve a company to introduce a new product that is inferior to the current standard of care. It must show statistically significant improvement. This is all IMHO based on my DD.
comments welcome